Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories

Journal of Hospital Infection

Volumn 68, Issue 4, 2008, Pages 315-321

  Fitzpatrick, F ^a,b   Oza, A ^a   Gilleece, A ^c   O'Byrne, A M ^d   Drudy, D ^e  

^a HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c Royal College of Surgeons in Ireland   (Ireland)

^d University College Dublin ^*

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Clostridium difficile; Laboratory diagnosis

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL PRACTICE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITERION VARIABLE; CYTOTOXICITY; DIARRHEA; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; FECES ANALYSIS; HEALTH CARE FACILITY; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; IRELAND; LABORATORY DIAGNOSIS; MICROBIOLOGY; MULTICENTER STUDY; NONHUMAN; PRACTICE GUIDELINE; QUESTIONNAIRE; TISSUE SECTION;

ADVISORY COMMITTEES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FECES; GUIDELINES AS TOPIC; HUMANS; IRELAND; LABORATORY TECHNIQUES AND PROCEDURES; QUESTIONNAIRES;

EID: 41549166000     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.01.025     Document Type: Article

References (27)

1. Department of Health and Children, Ireland. Infectious diseases (Amendment) regulations, 2000: Statutary Instrument No. 151 of 2000; S.I. No. 865 of 2004; 2004.
2. Fitzpatrick F. The Third Prevalence Survey of Healthcare-associated Infections in Acute Hospitals (2006), preliminary results, Republic of Ireland
3. Anon. Computerised infectious disease reporting (CIDR) (2007), Health Protection Surveillance Centre, Dublin
4. Al Barrak A., Embil J., Dyck B., et al. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 25 (1999) 65-69
5. Tachon M., Cattoen C., Blanckaert K., et al. First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. Euro Surveill 11 5 (2006) E060504.1
6. van Steenbergen J., Debast S., van Kregten E., van den Berg R., Notermans D., and Kuijper E. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea. Euro Surveill 10 7 (2005) E050714.1
7. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
8. Kuijper E.J., Coignard B., and Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12 Suppl. 6 (2006) 2-18
9. Kyne L., Merry C., O'Connell B., Harrington P., Keane C., and O'Neill D. Simultaneous outbreaks of two strains of toxigenic Clostridium difficile in a general hospital. J Hosp Infect 38 (1998) 101-112
10. Barbut F., Delmee M., Brazier J.S., et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9 (2003) 989-996
11. Taylor J., Foster K., and Berrington A. Clostridium difficile: a questionnaire survey of laboratory practice in England, Wales, and Northern Ireland. Commun Dis Public Health 7 (2004) 322-327
12. Alfa M.J., Du T., and Beda G. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol 36 (1998) 2076-2080
13. National Clostridium difficile Standards Group: report to the Department of Health. J Hosp Infect 56 Suppl. 1 (2004) 1-38
14. Berrington A., and Settle C.D. Which specimens should be tested for Clostridium difficile toxin?. J Hosp Infect 65 (2007) 280-282
15. Gerding D.N., Johnson S., Peterson L.R., Mulligan M.E., and Silva J. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 16 (1995) 459-477
16. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92 (1997) 739-750
17. Katz D.A., Lynch M.E., and Littenberg B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 100 (1996) 487-495
18. Chernak E., Johnson C.C., Weltman A., et al. Severe Clostridium difficile-associated disease in populations previously at low risk - four states. Morb Mortal Wkly Rep 2005 54 (2005) 1201-1205
19. Brazier J.S., Fawley W., Freeman J., and Wilcox M.H. Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother 48 (2001) 741-742
20. Cullen S., Conlon M., Fanning S., Barry H., O'Connell B., and Drudy D. An Evaluation of Clostridium difficile testing and genetic determination of toxin positive strains from St. James's University Hospital (June 2007), Second International, Dublin, Ireland [abstract P7]
21. Finnegan M., FitzGerald S., Fenelon L., Fanning S., and Drudy D. Evaluation of ELISA, culture and real time PCR for the detection of Clostridium difficile in an Irish university hospital. Second International Clostridium difficile Symposium Slovenia (June 2007) [abstract P9]
22. Freeman J., and Wilcox M.H. The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol 56 (2003) 126-128
23. Delmee M., Van Broeck J., Simon A., Janssens M., and Avesani V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 54 (2005) 187-191
24. Lozniewski A., Rabaud C., Dotto E., Weber M., and Mory F. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of premier cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 39 (2001) 1996-1998
25. Poutanen S.M., and Simor A.E. Clostridium difficile-associated diarrhea in adults. CMAJ 171 (2004) 51-58
26. Anon. Management, prevention and surveillance of Clostridium difficile. Interim findings from a national survey of NHS acute trusts in England (2005), Health Protection Agency and the Healthcare Commission, London
27. Long S., Fenelon L., Fitzgerald S., et al. First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland. Eurosurveill Wkly 12 (2007) E070426.1